DNA X, Inc.: cash_and_equivalents
| Value | {"amount": 900000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2026-06-30) |
| Status | current |
| Entity | DNA X, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-28T09:47:47.746243+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5cebc6a6-35b3-4921-a80d-46b85e0413a7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-26-039226 · Open the official SEC filing →Retrieved: 2026-08-28T09:47:47.746243+02:00
Raw response sha256:
fe1f8c053e07a6f20e5f7b99fc60e9be…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178697/cash-and-equivalents/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5cebc6a6-35b3-4921-a80d-46b85e0413a7
History
- no predecessors — first report